Invizyne Technologies IPO: 4.3M Shrs at $4 Each

Biotechnology Company Invizyne Technologies Plans $4 IPO

Biotechnology firm Invizyne Technologies has announced its plans to launch an initial public offering (IPO), with the intention of selling 4.3 million shares at a price of $4 each. The company, known for its biomanufacturing platform SimplePath, aims to utilize the IPO to generate net proceeds of around $15.5 million, which could increase to $19.3 million if an overallotment option is exercised. Invizyne Technologies intends to allocate a portion of the funds towards expanding its staff and production capabilities, as well as for other corporate purposes. The biotech company has applied to list its shares on the Nasdaq Capital Market under the symbol IZTC.